Monday, March 20, 2023
Advertisement

Finland: Pihlajalinna intends to issue €20m in hybrid capital securities

Pihlajalinna, a leading provider of private healthcare and wellbeing services in Finland, is considering issuance of a minimum €20m (US$21.4m) in hybrid capital securities. Net...

Malaysia: KPJ raises debt and sells Indonesia assets

Point Zone, a subsidiary of KPJ Healthcare, the Malaysian based regional healthcare provider, is reported to have raised RM555m (US$123m) from a sukuk offering launched...

Israel: Redhill Bio places US$6m convertible promissory note with one investor

Redhill Biopharma, a specialty biopharmaceutical company, has placed a US$6m convertible promissory note (convertible into ADS) and warrants with a single investor. Advances under the...

New Zealand: Summerset raises NZ$150m from retail bond offering

Summerset Group Holdings, which develops, owns, and operates integrated retirement villages, has closed its fixed rate retail bond offer at a rate of 6.59%...

Early stage funding: Allorion Therapeutics, Logex, SiYi Intelligence, Vitraya Technologies

India: Vitraya Technologies, a technology platform that enables automated claims decision making for insurers and real-time payouts to providers, has raised US$4.1m in a...

Italy: Archimed acquires fast-growing consumer health player, WiQo

Global private equity healthcare specialist Archimed has acquired European consumer health player, WiQo. Archimed’s acquisition of the Muggia-based pioneer in aesthetic medicine will accelerate...

Singapore: Natixis CIB closes hybrid facility for R-Bridge Healthcare Fund

Natixis Corporate & Investment Banking, part of BPCE the second largest banking group in France. recently closed a US$120m hybrid facility for R-Bridge Healthcare...

Switzerland: GeNeuro signs credit agreement with EIB to help fund long-Covid trials

Geneva-based GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, has signed a credit agreement for up to €25m (US$26.4m) with...

Switzerland: Noema Pharma closes Series B at CHF103m

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, has closed an oversubscribed Series B financing round, raising CHF103m (US$112m) from...

Australia: Australian Unity looks to raise A$350m to fund acquisitions and strengthen balance sheet

Australian Unity’s A$3.8bn (US$2.5bn) Healthcare Property Trust (AUHPT)—the largest unlisted healthcare REIT in Australia—has re-opened to seek to raise approximately A$350m to provide funding...